Latest Insider Transactions at Fulgent Genetics, Inc. (FLGT)
This section provides a real-time view of insider transactions for Fulgent Genetics, Inc. (FLGT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Fulgent Genetics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Fulgent Genetics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,796
-0.4%
|
$62,860
$35.89 P/Share
|
|
Nov 16
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,306
-0.3%
|
$45,710
$35.89 P/Share
|
|
Nov 07
2022
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,723
+5.4%
|
-
|
|
Nov 07
2022
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Indirect |
220,816
+50.0%
|
-
|
|
Nov 07
2022
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
129,309
+23.03%
|
-
|
|
Nov 07
2022
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
220,816
+50.0%
|
$8,611,824
$39.02 P/Share
|
|
Nov 07
2022
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
566,171
+48.71%
|
$22,080,669
$39.02 P/Share
|
|
Nov 07
2022
|
Paul Kim CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
77,585
+25.57%
|
-
|
|
Nov 03
2022
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,240
-0.83%
|
$45,880
$37.89 P/Share
|
|
Nov 03
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,198
-2.01%
|
$229,326
$37.89 P/Share
|
|
Nov 01
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
775
-0.25%
|
$31,000
$40.25 P/Share
|
|
Oct 30
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-0.01%
|
$3,040
$40.28 P/Share
|
|
Sep 06
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
662
-0.44%
|
$27,142
$41.39 P/Share
|
|
Aug 30
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
675
-0.22%
|
$29,700
$44.18 P/Share
|
|
Aug 17
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
370
-0.04%
|
$17,760
$48.89 P/Share
|
|
Aug 17
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,945
-1.28%
|
$93,360
$48.89 P/Share
|
|
Aug 17
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,414
-0.45%
|
$67,872
$48.89 P/Share
|
|
Aug 03
2022
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,048
-0.68%
|
$64,976
$62.93 P/Share
|
|
Aug 03
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,343
-1.99%
|
$393,266
$62.93 P/Share
|
|
Aug 01
2022
|
Michael Nohaile |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
|
Aug 01
2022
|
Ming Hsieh Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Aug 01
2022
|
Leonard E Post Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Aug 01
2022
|
Linda Marsh |
BUY
Grant, award, or other acquisition
|
Direct |
1,600
+22.22%
|
-
|
|
Aug 01
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-0.27%
|
$51,448
$59.54 P/Share
|
|
Aug 01
2022
|
John C Bolger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,600
+23.88%
|
-
|
|
Jul 30
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.01%
|
$5,133
$59.75 P/Share
|
|
Jun 02
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
415
-0.27%
|
$22,825
$55.1 P/Share
|
|
May 31
2022
|
John C Bolger Director |
SELL
Open market or private sale
|
Direct |
1,126
-9.0%
|
$61,930
$55.34 P/Share
|
|
May 31
2022
|
John C Bolger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
626
+6.77%
|
$2,504
$4.87 P/Share
|
|
May 31
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
668
-0.21%
|
$36,072
$54.54 P/Share
|
|
May 19
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
10,000
-3.03%
|
$580,000
$58.29 P/Share
|
|
May 18
2022
|
John C Bolger Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+33.33%
|
-
|
|
May 18
2022
|
Linda Marsh |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+33.33%
|
-
|
|
May 18
2022
|
Yun Yen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|
|
May 16
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
325
-0.04%
|
$17,225
$53.38 P/Share
|
|
May 16
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,191
-0.39%
|
$63,123
$53.38 P/Share
|
|
May 16
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,269
-0.38%
|
$67,257
$53.38 P/Share
|
|
May 03
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,904
-1.75%
|
$330,624
$56.69 P/Share
|
|
May 03
2022
|
Paul Kim CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
806
-0.52%
|
$45,136
$56.69 P/Share
|
|
May 01
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-0.22%
|
$39,852
$54.88 P/Share
|
|
Apr 30
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
283
-0.03%
|
$15,282
$54.88 P/Share
|
|
Mar 03
2022
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
454
-0.29%
|
$25,424
$56.31 P/Share
|
|
Mar 01
2022
|
John C Bolger Director |
SELL
Open market or private sale
|
Direct |
1,875
-23.81%
|
$114,375
$61.36 P/Share
|
|
Mar 01
2022
|
John C Bolger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+19.23%
|
$15,000
$8.52 P/Share
|
|
Mar 01
2022
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
622
-0.18%
|
$39,186
$63.3 P/Share
|
|
Feb 28
2022
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+2.34%
|
-
|
|
Feb 28
2022
|
Paul Kim CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+11.89%
|
-
|
|
Feb 28
2022
|
Jian Xie President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
41,000
+5.75%
|
-
|
|
Feb 15
2022
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
936
-0.31%
|
$61,776
$66.49 P/Share
|
|
Feb 15
2022
|
Hanlin Gao Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-0.04%
|
$19,998
$66.49 P/Share
|